3,7,12-trihydroxycoprostanic acid has been researched along with clofibric acid in 1 studies
| Studies (3,7,12-trihydroxycoprostanic acid) | Trials (3,7,12-trihydroxycoprostanic acid) | Recent Studies (post-2010) (3,7,12-trihydroxycoprostanic acid) | Studies (clofibric acid) | Trials (clofibric acid) | Recent Studies (post-2010) (clofibric acid) |
|---|---|---|---|---|---|
| 31 | 0 | 0 | 1,429 | 103 | 120 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blomhoff, R; Farrants, AK; Nilsson, A; Pedersen, JI; Trøen, G | 1 |
1 other study(ies) available for 3,7,12-trihydroxycoprostanic acid and clofibric acid
| Article | Year |
|---|---|
The effect of retinoids and clofibric acid on the peroxisomal oxidation of palmitic acid and of 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoic acid in rat and rabbit hepatocytes.
Topics: Animals; Cells, Cultured; Cholic Acids; Clofibric Acid; Isomerism; Liver; Liver Neoplasms, Experimental; Microbodies; Oxidation-Reduction; Palmitic Acid; Palmitic Acids; Rabbits; Rats; Retinoids; Tumor Cells, Cultured | 1993 |